ZUM BRUTVORKOMMEN DES AUSTERNFISCHERS (HAEMATOPUS OSTRALEGUS) IN DITHMARSCHEN = SUR LA COUVAISON DE H.O. DANS LE DITHMARSCHEGLOE P; BUSCHE G.1974; ORNITHOL. MITT.; DTSCH.; DA. 1974; VOL. 26; NO 8; PP. 147-151; BIBL. 17REF.Article

Chronic idiopathic myelofibrosis: prognostic impact of myelofibrosis and clinical parameters on event-free survival in 122 patients who presented in prefibrotic and fibrotic stages. A retrospective study identifying subgroups of different prognoses by using the RECPAM methodKREFT, A; WEISS, M; WIESE, B et al.Annals of hematology (Print). 2003, Vol 82, Num 10, pp 605-611, issn 0939-5555, 7 p.Article

Complete haematological and cytogenetic response to interferon alpha-2a of a myeloproliferative disorder with eosinophilia associated with a unique t(4;7) aberrationSCHÖFFSKI, P; GANSER, A; PASCHEBERG, U et al.Annals of hematology (Print). 2000, Vol 79, Num 2, pp 95-98, issn 0939-5555Article

Frequency of pseudo-Gaucher cells in diagnostic bone marrow biopsies from patients with Ph-positive chronic myeloid leukaemiaBÜSCHE, G; MAJEWSKI, H; SCHLUE, J et al.Virchows Archiv. 1997, Vol 430, Num 2, pp 139-148, issn 0945-6317Article

Systemic mastocytosis (SM) with associated BCR-ABL-positive myelogenous leukaemia (SM-AHNMD): evidence that mast cells do not belong to the leukaemic cloneHUSSEIN, K; HORNY, H.-P; BÜSCHE, G et al.Leukemia. 2011, Vol 25, Num 6, pp 1050-1053, issn 0887-6924, 4 p.Article

Molecular detection of c-mpl thrombopoietin receptor gene expression in chronic myeloproliferative disordersDUENSING, S; DUENSING, A; MERAN, J. G et al.MP. Molecular pathology. 1999, Vol 52, Num 3, pp 146-150, issn 1366-8714Article

Long-term transfusion independence in del(5q) MDS patients who discontinue lenalidomideGIAGOUNIDIS, Aan; KULASEKARARAJ, A; PLATZBECKER, U et al.Leukemia. 2012, Vol 26, Num 4, pp 855-858, issn 0887-6924, 4 p.Article

Lentiviral vectors for induction of self-differentiation and conditional ablation of dendritic cellsPINCHA, M; SALGUERO, G; BÜSCHE, G et al.Gene therapy (Basingstoke). 2011, Vol 18, Num 8, pp 750-764, issn 0969-7128, 15 p.Article

Telomere shortening, clonal evolution and disease progression in myelodysplastic syndrome patients with 5q deletion treated with lenalidomideGÖHRING, G; LANGE, K; SCHLEGELBERGER, B et al.Leukemia. 2012, Vol 26, Num 2, pp 356-358, issn 0887-6924, 3 p.Article